TWI496791B - Crosslinked chitosan and its preparation method - Google Patents

Crosslinked chitosan and its preparation method Download PDF

Info

Publication number
TWI496791B
TWI496791B TW099124102A TW99124102A TWI496791B TW I496791 B TWI496791 B TW I496791B TW 099124102 A TW099124102 A TW 099124102A TW 99124102 A TW99124102 A TW 99124102A TW I496791 B TWI496791 B TW I496791B
Authority
TW
Taiwan
Prior art keywords
acid
chitosan
anhydride
group
crosslinking agent
Prior art date
Application number
TW099124102A
Other languages
Chinese (zh)
Other versions
TW201204745A (en
Original Assignee
Univ Nat Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Taiwan filed Critical Univ Nat Taiwan
Priority to TW099124102A priority Critical patent/TWI496791B/en
Publication of TW201204745A publication Critical patent/TW201204745A/en
Application granted granted Critical
Publication of TWI496791B publication Critical patent/TWI496791B/en

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polyamides (AREA)

Description

經交聯之幾丁聚醣及其製備方法Cross-linked chitosan and preparation method thereof

本發明係關於一種經交聯之幾丁聚醣及其製備方法,特別係關於一種藉由醯胺鍵之形成產生交聯結構之幾丁聚醣及其製備方法。The present invention relates to a cross-linked chitosan and a preparation method thereof, and more particularly to a chitosan which produces a crosslinked structure by formation of a guanamine bond and a preparation method thereof.

幾丁聚醣由於具有抗菌活性、止血、促進組織再生、高生物相容性等優點,目前已廣泛應用於生醫用途上,例如作為生醫材料的骨架。Chitosan has been widely used in biomedical applications due to its antibacterial activity, hemostasis, tissue regeneration, and high biocompatibility, for example, as a skeleton of biomedical materials.

為了提升幾丁聚醣的功效,現有技術中有許多研究係著重於對幾丁聚醣進行修飾,而目前已知可用於修飾的生物材料包括膠原蛋白、褐藻酸、明膠等。In order to enhance the efficacy of chitosan, many studies in the prior art have focused on the modification of chitosan, and the biological materials currently known for modification include collagen, alginic acid, gelatin and the like.

此外,若將幾丁聚醣與其他成分進行物理或化學性之交聯(crosslink),則可得到機械強度較佳且具有特殊生醫用途之產物。舉例來說,若將戊二醛作為交聯劑使幾丁聚醣進行共價鍵交聯,將可產生特殊之微粒子結構,其不僅可用於藥物緩釋系統,亦可作為組織工程中使用之支架,此可參見Gupta,K.C.,et al.,Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman. Carbohydr Res,2007. 342(15): p. 2244-52。Further, if chitosan is physically or chemically cross-linked with other components, a product having better mechanical strength and having special biomedical use can be obtained. For example, if glutaraldehyde is used as a cross-linking agent to covalently crosslink chitosan, a special microparticle structure can be produced, which can be used not only in drug delivery systems but also in tissue engineering. Scaffolds, see Gupta, KC, et al., Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman. Carbohydr Res, 2007. 342(15): p. 2244-52.

除前述應用外,目前也已知在適當的交聯條件下可將幾丁聚醣應用於創傷敷料。舉例來說,本案發明人曾發現可將幾丁聚醣與聚麩胺酸形成聚錯合物(polyelectrolyte complex),並於冷凍乾燥後得到可應用於創傷敷料的不透明孔洞性支架材料。相較於未使用敷料的傷口,前述幾丁聚醣/聚麩胺酸複合支架對於傷口的癒合有顯著的幫助。由傷口的組織切片來看,幾丁聚醣對發炎細胞有抑制的作用,且對於纖維母細胞的增生有刺激的效果,而聚麩胺酸則是能增進上皮細胞的生長。此可參見林育永,幾丁聚醣/聚麩胺酸複合支架在創傷敷料之應用,國立臺灣大學高分子科學與工程學研究所碩士論文,2009年7月。In addition to the aforementioned applications, it is currently known to apply chitosan to wound dressings under appropriate crosslinking conditions. For example, the inventors of the present invention have discovered that chitosan can be formed into a polyelectrolyte complex with polyglutamic acid, and after lyophilization, an opaque porous scaffold material that can be applied to a wound dressing is obtained. The chitosan/poly glutamic acid composite scaffold described above has a significant contribution to wound healing compared to wounds without dressings. From the tissue section of the wound, chitosan has an inhibitory effect on inflammatory cells and has a stimulating effect on the proliferation of fibroblasts, while polyglutamic acid can enhance the growth of epithelial cells. This can be seen in Lin Yuyong, the application of chitosan/polyglutamic acid composite scaffold in wound dressing, Master's thesis of Institute of Polymer Science and Engineering, National Taiwan University, July 2009.

此外,亦有研究人員將幾丁聚醣分別與膠原蛋白、聚磷酸、玻尿酸等進行交聯,以得到不同性質而具有不同生醫應用之創傷敷料。In addition, researchers have also cross-linked chitosan with collagen, polyphosphoric acid, hyaluronic acid, etc. to obtain wound dressings with different properties and different biomedical applications.

然而,由於前述針對幾丁聚醣進行修飾的技術仍存在某些令人不甚滿意之處,如交聯劑戊二醛具有毒性、大部分產生之創傷敷料不具有透明性、製備過程效率較低...等,如何提出一種新穎之經修飾幾丁聚醣及其製備方法,並將其應用於創傷敷料或水膠,乃是本領域研究人員所欲積極突破者。However, due to the aforementioned techniques for modifying chitosan, there are still some unsatisfactory ones, such as the cross-linking agent glutaraldehyde is toxic, most of the wound dressings produced have no transparency, and the preparation process is more efficient. Low...etc. How to propose a novel modified chitosan and its preparation method and apply it to wound dressing or water gel is a positive breakthrough for researchers in this field.

有感於習知技術之缺憾,發明人遂竭其心智悉心研究,憑其從事該項產業多年所累積之經驗,進而研發出一種經交聯之幾丁聚醣及其製備方法,以作為新一代之水膠或創傷敷料,其具有令人滿意的透明度、吸水性、機械強度、化學穩定性等。Inspired by the shortcomings of the prior art, the inventor exhausted his mind and researched it, and based on his years of experience in the industry, he developed a cross-linked chitosan and its preparation method as a new A generation of water gel or wound dressing that has satisfactory transparency, water absorption, mechanical strength, chemical stability, and the like.

本發明之目的之一,在於提供一種經交聯之多醣,其單體包括葡萄糖胺及N-乙醯葡萄糖胺,且單體間彼此以β(1-4)糖苷鍵相連接,其中至少部分葡萄糖胺單體與交聯劑形成醯胺鍵。One of the objects of the present invention is to provide a crosslinked polysaccharide comprising glucosamine and N-acetylglucosamine, and the monomers are linked to each other by β(1-4) glycosidic bonds, at least in part. The glucosamine monomer forms a guanamine bond with the crosslinking agent.

於前述之經交聯之多醣中,交聯劑較佳係包括二元酸或其酸酐,且較佳係為胺基所取代。In the above-mentioned crosslinked polysaccharide, the crosslinking agent preferably includes a dibasic acid or an anhydride thereof, and is preferably substituted with an amine group.

於前述之經交聯之多醣中,交聯劑較佳係選自丙二酸、丁二酸、丁二酸酐、戊二酸、戊二酸酐、天門冬酸、麩胺酸以及具有至少兩個羧基之聚乳酸所組成之群組,且聚乳酸係包括乳酸寡聚物。In the above crosslinked polysaccharide, the crosslinking agent is preferably selected from the group consisting of malonic acid, succinic acid, succinic anhydride, glutaric acid, glutaric anhydride, aspartic acid, glutamic acid, and at least two A group consisting of a polylactic acid of a carboxyl group, and a polylactic acid type includes a lactic acid oligomer.

此外,於一較佳之實施例中,前述多醣於交聯前之分子量係介於60kDa至800kDa之間,其去乙醯度(degree of deacetylation,DD)係大於80%,且-NH3 + 對-COO- 之重複單元比例(repeating unit ratio)係介於1:1至9:1之間。於另一較佳實施例中,交聯劑可為乳酸寡聚物,其具有至少兩個羧基,且分子量較佳係介於300~3000之間,更佳係約為500、1000或2000。In addition, in a preferred embodiment, the molecular weight of the polysaccharide before crosslinking is between 60 kDa and 800 kDa, and the degree of deacetylation (DD) is greater than 80%, and the -NH 3 + pair -COO - The repeating unit ratio is between 1:1 and 9:1. In another preferred embodiment, the crosslinking agent can be a lactic acid oligomer having at least two carboxyl groups and preferably having a molecular weight of between 300 and 3000, more preferably about 500, 1000 or 2000.

前述經交聯之多醣係可應用於吸濕性材料中,如尿布、女性用品、面膜等,且較佳係作為創傷敷料。The crosslinked polysaccharide described above can be applied to a hygroscopic material such as a diaper, a feminine article, a mask, etc., and is preferably used as a wound dressing.

本發明之再一目的,在於提供一種包含幾丁聚醣之水膠,其中至少部分葡萄糖胺單體與交聯劑形成醯胺鍵,且交聯劑較佳係為天然小分子酸或其酸酐,且可選自丙二酸、丁二酸、丁二酸酐、戊二酸、戊二酸酐、天門冬酸、麩胺酸以及具有至少兩個羧基之聚乳酸所組成之群組。A further object of the present invention is to provide a water gel comprising chitosan, wherein at least a part of the glucosamine monomer forms a guanamine bond with a crosslinking agent, and the crosslinking agent is preferably a natural small molecule acid or an anhydride thereof. And may be selected from the group consisting of malonic acid, succinic acid, succinic anhydride, glutaric acid, glutaric anhydride, aspartic acid, glutamic acid, and polylactic acid having at least two carboxyl groups.

本發明之又一目的,在於提供一種經交聯之幾丁聚醣,其具有如式I所示之部分結構:It is still another object of the present invention to provide a crosslinked chitosan having a partial structure as shown in Formula I:

於較佳之實施例中,X係為經取代或未經取代之C1 -C5 伸烷基,且其較佳係為胺基所取代。In a preferred embodiment, X is a substituted or unsubstituted C 1 -C 5 alkylene group, and is preferably substituted with an amine group.

此外,本發明之目的之一,在於提供一種製備經交聯之幾丁聚醣之方法,包括利用二元酸或二元酸酐使幾丁聚醣藉由醯胺鍵之形成產生交聯結構。Further, it is an object of the present invention to provide a process for preparing a crosslinked chitosan comprising using a dibasic acid or a dibasic acid anhydride to form a crosslinked structure by formation of a guanamine bond.

於前述方法中,交聯結構之產生較佳係於碳二亞胺之存在下進行,且更佳係於N,N-(3-二甲胺丙基)-N’-乙基-碳二亞胺以及N-羥基-琥珀醯亞胺之存在下進行。此外,N,N-(3-二甲胺丙基)-N’-乙基-碳二亞胺以及N-羥基-琥珀醯亞胺較佳係溶於醇類(如乙醇)中。In the above method, the crosslinking structure is preferably produced in the presence of carbodiimide, and more preferably in N,N-(3-dimethylaminopropyl)-N'-ethyl-carbon two. It is carried out in the presence of an imine and N-hydroxy-succinimide. Further, N,N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide and N-hydroxy-succinimide are preferably dissolved in an alcohol such as ethanol.

為充分說明本發明之目的、特徵及功效,使本發明所屬技術領域中具有通常知識者能瞭解本發明之內容並可據以實施,茲藉由下述具體之實施例配合所附之圖式,對本發明做一詳細說明如後。To fully clarify the objects, features, and advantages of the present invention, those of ordinary skill in the art of the present invention can understand the invention and practice the invention. A detailed description of the present invention will be given.

名詞定義Noun definition

於本發明中,「幾丁聚醣」係指為幾丁質進行去乙醯化後所得之產物,其屬於一種線性之多醣,且單體為隨機分佈的葡萄糖胺與N-乙醯葡萄糖胺,彼此間以β(1-4)糖苷鍵相接。In the present invention, "chitosan" refers to a product obtained by deacetylation of chitin, which belongs to a linear polysaccharide, and the monomers are randomly distributed glucosamine and N-acetylglucosamine. They are joined to each other by a β(1-4) glycosidic bond.

於本發明中,「去乙醯度」係指幾丁聚醣分子中葡萄糖胺所佔有的莫耳比率。In the present invention, "de-acetylation degree" means the molar ratio occupied by glucosamine in the chitosan molecule.

於本發明中,「交聯」係指聚合物分子鏈之間或之內兩個以上之特定官能基藉由交聯劑而形成架橋結構。舉例而言,一幾丁聚醣分子鏈中的葡萄糖胺單體上的胺基,可藉由二元酸作為交聯劑,而與另一幾丁聚醣分子鏈中的葡萄糖胺單體上的胺基進行交聯。In the present invention, "crosslinking" means that two or more specific functional groups between or within a polymer molecular chain form a bridging structure by a crosslinking agent. For example, an amine group on a glucosamine monomer in a chitosan molecular chain can be used as a crosslinking agent by a dibasic acid, and a glucosamine monomer in another molecular chain of chitosan The amine group is crosslinked.

於本發明中,「水膠」係指一種非水溶性聚合物材料,水膠可於水中吸水膨脹,進而將水保持於其結構中。此外,如本發明所屬技術領域中具有通常知識者所知,水膠係與乾凝膠(xerogel)、泡棉(sponge)、氣膠(aerogel)不相同。In the present invention, "water gel" means a water-insoluble polymer material which is swellable in water to retain water in its structure. Moreover, as is known to those of ordinary skill in the art to which the present invention pertains, the water gel system is not the same as xerogel, sponge, or aerogel.

水膠製備Water gel preparation

將0.8克幾丁聚醣粉末在室溫下溶解於20mL之2.0%(v/v)醋酸水溶液中,之後進行攪拌直至粉末完全溶解,以製得4.0%(w/w)之幾丁聚醣溶液,之後再將溶液靜置一晚以去除溶液中的泡泡。於一實施例中,所使用之幾丁聚醣的平均分子量為300kDa,去乙醯度為97%,然其平均分子量亦可介於60kDa至800kDa,且去乙醯度可大於80%。0.8 g of chitosan powder was dissolved in 20 mL of a 2.0% (v/v) aqueous acetic acid solution at room temperature, followed by stirring until the powder was completely dissolved to obtain 4.0% (w/w) chitosan. The solution was then allowed to stand overnight for removal of bubbles in the solution. In one embodiment, the chitosan used has an average molecular weight of 300 kDa and a deacetylation degree of 97%, but the average molecular weight may also range from 60 kDa to 800 kDa, and the degree of deacetylation may be greater than 80%.

分別將麩胺酸、丁二酸、丁二酸酐溶解於去離子水中,之後將此等二元酸或其酸酐溶液分散於幾丁聚醣溶液中並均勻攪拌。接著,再將作為催化劑之N,N-(3-二甲胺丙基)-N’-乙基-碳二亞胺(EDC)以及N-羥基-琥珀醯亞胺(NHS)加入,以促進醯胺鍵之形成。之後溶液乃於60℃下攪拌均勻,以得到透明的水膠。The glutamic acid, succinic acid, and succinic anhydride are separately dissolved in deionized water, and then the dibasic acid or its anhydride solution is dispersed in the chitosan solution and uniformly stirred. Next, N,N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide (EDC) and N-hydroxy-succinimide (NHS) as catalysts are added to promote Formation of a guanamine bond. The solution was then stirred at 60 ° C to obtain a clear water gel.

於本發明中,醯胺鍵之形成亦可不需於催化劑之存在下進行,舉例來說,醯胺鍵之形成可於高溫與減壓之環境下進行而不使用催化劑。此外,為提高交聯反應的進行,N,N-(3-二甲胺丙基)-N’-乙基-碳二亞胺以及N-羥基-琥珀醯亞胺較佳係溶解於乙醇之中。In the present invention, the formation of a guanamine bond may not be carried out in the presence of a catalyst. For example, the formation of a guanamine bond may be carried out in an environment of high temperature and reduced pressure without using a catalyst. Further, in order to enhance the progress of the crosslinking reaction, N,N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide and N-hydroxy-succinimide are preferably dissolved in ethanol. in.

於本發明中,所使用的幾丁聚醣/二元酸或其酸酐之重複單元比例可為90/10至50/50,但不以此為限,如80/20、75/25、70/30、67/33、60/40等。為便於說明,以下乃列出製備不同重複單元比例之水膠所使用的幾丁聚醣及二元酸之重量以及水膠之凝膠率(gel fraction),其中C50S50代表幾丁聚醣(chitosan,以C代表)對於丁二酸(succinic acid,以S代表)之重複單元比例為50:50,C80S20代表幾丁聚醣對於丁二酸之重複單元比例為80:20,C50G50代表幾丁聚醣對於麩胺酸(glutamic acid,以G代表)之重複單元比例為50:50,依此類推;且凝膠率係以下式計算而得In the present invention, the ratio of the repeating unit of the chitosan/dibasic acid or its anhydride may be from 90/10 to 50/50, but not limited thereto, such as 80/20, 75/25, 70. /30, 67/33, 60/40, etc. For convenience of explanation, the following is a list of the weight of chitosan and dibasic acid used in the preparation of different repeating unit ratios and the gel fraction of the water gel, wherein C50S50 represents chitosan (chitosan) The ratio of repeating units for succinic acid (represented by S) is 50:50, C80S20 represents the ratio of repeating units of chitosan to succinic acid is 80:20, and C50G50 represents chitosan. The ratio of sugar to glutamic acid (represented by G) is 50:50, and so on; and the gel fraction is calculated by the following formula.

凝膠率=(水膠原始重量-水膠浸泡水中三天後烘乾的重量)÷水膠原始重量。Gel rate = (the original weight of the water gel - the weight of the water gel after three days of soaking in water) the original weight of the water gel.

性質分析Property analysis

為分析不同重複單元比例之幾丁聚醣/丁二酸水膠、幾丁聚醣/丁二酸酐水膠以及幾丁聚醣/麩胺酸水膠之物化性質,乃對所製得之各種水膠進行以下分析:In order to analyze the physicochemical properties of chitosan/succinic acid water gel, chitosan/succinic anhydride water gel and chitosan/glutamic acid water gel with different repeating unit ratios, The water gel is analyzed as follows:

A. FTIR光譜A. FTIR spectroscopy

使用FTIR光譜儀(Perkin-Elmer Spectrum RX1 System)對所製得之水膠進行分析,以檢驗其成分中胺基與羧基的信號變化。The prepared water gel was analyzed using an FTIR spectrometer (Perkin-Elmer Spectrum RX1 System) to examine the signal changes of the amine group and the carboxyl group in the composition.

檢驗結果顯示經交聯之水膠在1631cm-1 與1587cm-1 處均有出現吸收峰,此可確認醯胺鍵係於交聯過程中形成。The test results showed that the crosslinked water gel showed absorption peaks at 1631 cm -1 and 1587 cm -1 , which confirmed that the indole bond was formed during the crosslinking.

B. 膨脹率B. Expansion ratio

先將所製得之水膠浸入0.05M之磷酸鹽緩衝生理食鹽水溶液(PBS)中,待達到穩態後,以濾紙吸去表面的液體,進而量測膨脹後水膠之濕重,並以下式計算水膠之膨脹率:The prepared water gel is first immersed in 0.05M phosphate buffered physiological saline solution (PBS). After reaching the steady state, the surface liquid is sucked by the filter paper, and then the wet weight of the water gel after expansion is measured, and below Calculate the expansion rate of water gel:

膨脹率=(濕重-乾重)÷乾重Expansion ratio = (wet weight - dry weight) dry weight

其中乾重與濕重分別代表水膠浸入PBS前、後所量測得的重量。The dry weight and the wet weight respectively represent the weight measured before and after the water gel is immersed in the PBS.

結果顯示所有的水膠於浸入PBS三小時後即達到穩態,且膨脹率隨著重複單元比例增加而增加。換言之,幾丁聚醣/交聯劑為80/20之水膠的膨脹率大於幾丁聚醣/交聯劑為50/50之水膠。當重複單元比例為50/50時,由於所形成之交聯數量最多,其所含有之孔隙較少而吸收較少之水分,且膨脹率最低。此外,量測結果顯示含有幾丁聚醣/麩胺酸(pKa為2.10與4.07)之水膠,相較於幾丁聚醣/丁二酸(pKa為4.20與5.60)與幾丁聚醣/丁二酸酐,具有較低之膨脹率。此外,測試結果也發現,以二元酸與二元酸酐作為交聯劑所得到的水膠具有大致相同的膨脹率。The results showed that all of the water gel reached a steady state three hours after immersion in PBS, and the expansion rate increased as the proportion of repeating units increased. In other words, the chitosan/crosslinking agent is an 80/20 water gel having a swelling ratio greater than that of a chitosan/crosslinking agent of 50/50. When the repeating unit ratio is 50/50, since the number of crosslinks formed is the largest, it contains less pores and absorbs less water, and the swelling ratio is the lowest. In addition, the measurement results showed a water gel containing chitosan/glutamic acid (pKa of 2.10 and 4.07) compared to chitosan/succinic acid (pKa of 4.20 and 5.60) and chitosan/ Succinic anhydride has a lower expansion ratio. In addition, the test results also found that the water gel obtained by using a dibasic acid and a dibasic acid anhydride as a crosslinking agent has substantially the same expansion ratio.

C. 壓縮模數C. Compression modulus

使用通用試驗機來量測水膠之壓縮模數。於測試過程中,水膠係以0.5mm/min之速率進行壓縮,並取壓縮應力-應變(stress-strain)圖中5%-35%形變之斜率進行分析。A universal testing machine was used to measure the compression modulus of the water gel. During the test, the water gel was compressed at a rate of 0.5 mm/min and analyzed by the slope of 5%-35% deformation in a compressive stress-strain diagram.

分析結果顯示,幾丁聚醣之壓縮強度會因為交聯結構之形成而增加,且幾丁聚醣/交聯劑為50/50之水膠顯示最高的壓縮模數,此結果與前述膨脹率之分析結果一致,即幾丁聚醣/交聯劑為50/50之水膠因為交聯度最高而具有最小之孔徑度。此外,由於反應性與交聯度較高,幾丁聚醣/麩胺酸顯示出較高的壓縮模數。The analysis results show that the compressive strength of chitosan is increased by the formation of crosslinked structure, and the 50/50 water gel of chitosan/crosslinking agent shows the highest compression modulus, and the result is the same as the expansion ratio. The analysis results are consistent, that is, the 50/50 water gel of chitosan/crosslinking agent has the smallest pore size because of the highest degree of crosslinking. In addition, chitosan/glutamic acid exhibits a higher compression modulus due to higher reactivity and higher degree of crosslinking.

D. 熱性質分析D. Thermal properties analysis

D1. 熱重分析(TGA)D1. Thermogravimetric Analysis (TGA)

以Perkin Elmer 7系列之熱重分析儀分析水膠之裂解溫度,溫度係以10℃/分鐘之速率由100℃升高至800℃,且於過程中持續記錄溫度及樣本質量。The cracking temperature of the water gel was analyzed using a Perkin Elmer 7 series thermogravimetric analyzer. The temperature was increased from 100 ° C to 800 ° C at a rate of 10 ° C / min, and the temperature and sample quality were continuously recorded during the process.

分析結果顯示,隨著鍵結的形成,水膠的重量損失也由二階段轉變成一階段。此外,由於二元酸之熱穩定性較幾丁聚醣差,5%裂解溫度隨著二元酸數量之增加而降低,且殘重亦與二元酸數量呈反比。The analysis results show that the weight loss of the water gel changes from two stages to one stage with the formation of the bond. In addition, since the thermal stability of the dibasic acid is inferior to that of chitosan, the 5% cleavage temperature decreases as the amount of the dibasic acid increases, and the residual weight is also inversely proportional to the amount of the dibasic acid.

D2. 示差掃描熱析(DSC)D2. Differential Scanning Thermal Analysis (DSC)

以Perkin Elmer之Pyris 6示差掃描熱析儀繪製水膠之溫度記錄圖,量測過程係於10℃/分鐘之加熱速率下進行並配合氮氣吹洗,溫度係由50℃升高至200℃。The temperature record of the water gel was drawn by Perkin Elmer's Pyris 6 differential scanning calorimeter. The measurement was carried out at a heating rate of 10 ° C / min and with nitrogen purge, and the temperature was raised from 50 ° C to 200 ° C.

由DSC溫度記錄圖可觀察到,水氣之重量損失隨著二元酸比例之增加而增加,此乃由於二元酸較幾丁聚醣更為親水所致。此外,由峰值偏移的現象來看,可知材料的含水量有增加的情形。由溫度記錄圖中亦可發現,當交聯密度增加時,材料之玻璃轉移溫度Tg也會增加或消失,此係因為交聯結構破壞了幾丁聚醣之排列。It can be observed from the DSC temperature record that the weight loss of water vapor increases as the ratio of dibasic acid increases, which is due to the fact that the dibasic acid is more hydrophilic than chitosan. Further, from the phenomenon of peak shift, it is known that the water content of the material increases. It can also be seen from the temperature record that as the crosslink density increases, the glass transition temperature Tg of the material also increases or disappears because the crosslinked structure destroys the arrangement of chitosan.

E. 生物降解分析E. Biodegradation analysis

於模擬之生理條件下,量測樣本重量隨著時間的變化,藉此評估樣本的生物降解速率。在量測樣本之初始重量後,於37℃下將樣本浸入20ml、含有58,100單位/ml溶菌酶的0.1M PBS中28天,之後計算重量損失百分比。The simulated sample weight was measured over time under simulated physiological conditions to thereby assess the biodegradation rate of the sample. After measuring the initial weight of the sample, the sample was immersed in 20 ml of 0.1 M PBS containing 58,100 units/ml lysozyme at 37 ° C for 28 days, after which the weight loss percentage was calculated.

結果顯示,幾丁聚醣在未進行交聯時,其降解情形最為嚴重,重量損失約為33%,且降解速率相當穩定。相較之下,幾丁聚醣/交聯劑為50/50之水膠則沒有明顯的降解現象,原因可能有二:一、幾丁聚醣與交聯劑形成緊密的交聯結構;二、材料的孔徑較小,故其接觸溶菌酶的表面積亦較小。The results showed that the degradation of chitosan was the most serious when the cross-linking was not carried out, the weight loss was about 33%, and the degradation rate was quite stable. In contrast, the chitosan/crosslinking agent is 50/50 water gel, there is no obvious degradation phenomenon, there may be two reasons: one, chitosan and cross-linking agent form a tight cross-linking structure; The material has a small pore size, so its surface area in contact with lysozyme is also small.

動物實驗Animal experiment

A. 切傷實驗A. Cutting experiment

先將ICR雄鼠(30-35g)以乙醚麻醉,於剃毛後以剪刀於鼠背部形成1cm寬的傷口,並將前述幾丁聚醣/交聯劑為50/50之水膠敷材以及由未經交聯之純幾丁聚醣製成的敷材放置於傷口上,觀察傷口之變化。ICR male rats (30-35g) were first anesthetized with ether, and after shaving, a 1 cm wide wound was formed on the back of the mouse with scissors, and the above chitosan/crosslinking agent was 50/50 water gel and A cast material made of uncrosslinked pure chitosan was placed on the wound to observe changes in the wound.

第1圖係為第三天傷口以H&E染色法進行染色所得之照片,其中第1a圖為控制組,即未使用任何敷材者;第1b圖為使用未進行交聯之幾丁聚醣敷材者;第1c~1e圖則分別為使用50/50之幾丁聚醣/麩胺酸敷材、50/50之幾丁聚醣/丁二酸酐敷材以及50/50之幾丁聚醣/丁二酸敷材者。於圖中,Epi表示表皮層;K表示角質;N表示新生血管;F表示毛囊;In表示發炎細胞;而箭頭所指處為角質。Figure 1 is a photograph of the third day of wound staining by H&E staining, in which Figure 1a is the control group, ie no applicator is used; Figure 1b is the use of un-crosslinked chitosan coating. The 1c~1e plan uses 50/50 chitosan/glutamic acid dressing, 50/50 chitosan/succinic anhydride dressing and 50/50 chitosan / Succinic acid applicator. In the figure, Epi denotes the epidermal layer; K denotes keratin; N denotes a new blood vessel; F denotes a hair follicle; In denotes an inflammatory cell; and the arrow points to keratin.

由第1圖中可以發現,於傷口形成後第三天,使用50/50之幾丁聚醣/麩胺酸敷材之傷口處的表皮層與角質層較其他敷材來得厚,且血管的出現代表已開始進行血管新生,相較之下,控制組的傷口處則觀察不到前述現象。對於幾丁聚醣/麩胺酸敷材而言,由於麩胺酸具有帶正電的胺基,故可讓細胞更容易附著至敷材上,進而加速組織的修復與再生。It can be found from Fig. 1 that on the third day after wound formation, the epidermis and stratum corneum of the 50/50 chitosan/glutamic acid dressing are thicker than other cast materials, and the blood vessels are The appearance of angiogenesis has begun, and the aforementioned phenomenon is not observed in the wounds of the control group. For chitosan/glutamic acid dressings, since glutamic acid has a positively charged amine group, cells can be more easily attached to the dressing, thereby accelerating the repair and regeneration of the tissue.

B.燙傷實驗B. Burning experiment

於ICR雄鼠(30-35g)背部形成2cm×1.5cm的中度燙傷傷口,並分別將不同重複單元比例之幾丁聚醣/麩胺酸敷材放置於傷口上,觀察傷口之變化。A moderately scalded wound of 2 cm x 1.5 cm was formed on the back of the ICR male (30-35 g), and chitosan/glutamic acid dressings of different repeating unit ratios were placed on the wound to observe changes in the wound.

第2圖係為第六天傷口以H&E染色法進行染色所得之照片,其中第2a圖為控制組,即未使用任何敷材者;第2b圖為使用未進行交聯之幾丁聚醣敷材者;第2c~2f圖則分別為使用80/20、75/25、67/33、50/50之幾丁聚醣/麩胺酸敷材者。Figure 2 is a photograph of the wound on the sixth day stained by H&E staining, in which Fig. 2a is the control group, that is, no applicator is used; and Fig. 2b is the chitosan coating without cross-linking. The 2c~2f plans are those using 80/20, 75/25, 67/33, 50/50 chitosan/glutamic acid perfusate.

由第2圖中可以發現,於傷口形成後第六天,比起控制組,所有敷上幾丁聚醣/麩胺酸敷材的傷口,角質層的修復均較完整(厚),而敷上純幾丁聚醣敷材的傷口角質層的修復則仍在進行中(薄)。此外,控制組上有傷口浸潤的現象(發炎細胞),而其他五組則均已消退。若比較敷上幾丁 聚醣/麩胺酸敷材的傷口,可以發現75/25、67/33、50/50的真皮層均在修復的過程中,且又以CS50/G50的真皮層最完整。It can be found from Fig. 2 that on the sixth day after the wound is formed, all the wounds coated with chitosan/glutamic acid dressing are more complete (thick) than the control group. The repair of the wound stratum corneum of the pure chitosan-coated material is still in progress (thin). In addition, there was a phenomenon of wound infiltration in the control group (inflamed cells), while the other five groups had subsided. If it is put on a few In the wound of glycan/glutamic acid dressing, it can be found that the dermis layers of 75/25, 67/33 and 50/50 are in the process of repair, and the dermis layer of CS50/G50 is the most complete.

本發明在上文中已以較佳實施例揭露,然本領域具有通常知識者應理解的是,該實施例僅用於描述本發明,而不應解讀為限制本發明之範圍。應注意的是,舉凡與該實施例等效之變化與置換,均應視為涵蓋於本發明之範疇內。因此,本發明之保護範圍當以下文之申請專利範圍所界定者為準。The present invention has been disclosed in its preferred embodiments, and it should be understood by those of ordinary skill in the art that the present invention is not intended to limit the scope of the invention. It should be noted that variations and permutations equivalent to those of the embodiments are considered to be within the scope of the invention. Therefore, the scope of the invention is defined by the scope of the following claims.

第1a圖至第1e圖係為第三天傷口以H&E染色法進行染色所得之照片;第2a圖至第2f圖係為第六天傷口以H&E染色法進行染色所得之照片。Fig. 1a to Fig. 1e are photographs obtained by dyeing the wound on the third day by H&E staining; Fig. 2a to Fig. 2f are photographs obtained by dyeing the wound on the sixth day by H&E staining.

Claims (13)

一種經交聯之多醣,其單體包括葡萄糖胺及N-乙醯葡萄糖胺,且單體間彼此以β(1-4)糖苷鍵相連接,其中至少部分葡萄糖胺單體與交聯劑形成醯胺鍵。 A crosslinked polysaccharide comprising glucosamine and N-acetylglucosamine, and the monomers are linked to each other by a β(1-4) glycosidic bond, wherein at least a portion of the glucosamine monomer and the crosslinking agent are formed. Amidoxime bond. 如申請專利範圍第1項所述之經交聯之多醣,其中該交聯劑包括二元酸或其酸酐。 The crosslinked polysaccharide of claim 1, wherein the crosslinking agent comprises a dibasic acid or an anhydride thereof. 如申請專利範圍第1項所述之經交聯之多醣,其中該交聯劑係選自丙二酸、丁二酸、丁二酸酐、戊二酸、戊二酸酐、天門冬酸、麩胺酸以及具有至少兩個羧基之聚乳酸所組成之群組。 The crosslinked polysaccharide according to claim 1, wherein the crosslinking agent is selected from the group consisting of malonic acid, succinic acid, succinic anhydride, glutaric acid, glutaric anhydride, aspartic acid, glutamine A group consisting of an acid and a polylactic acid having at least two carboxyl groups. 一種水膠,包含幾丁聚醣,其中至少部分葡萄糖胺單體與交聯劑形成醯胺鍵。 A water gel comprising chitosan wherein at least a portion of the glucosamine monomer forms a guanamine linkage with a crosslinking agent. 如申請專利範圍第4項所述之水膠,其中該交聯劑係選自丙二酸、丁二酸、丁二酸酐、戊二酸、戊二酸酐、天門冬酸、麩胺酸以及具有至少兩個羧基之乳酸寡聚物所組成之群組。 The water gel of claim 4, wherein the crosslinking agent is selected from the group consisting of malonic acid, succinic acid, succinic anhydride, glutaric acid, glutaric anhydride, aspartic acid, glutamic acid, and a group consisting of at least two carboxylated lactic acid oligomers. 一種經交聯之幾丁聚醣,具有如式I所示之部分結構: 其中X為經取代或未經取代之C1 -C5 伸烷基。A cross-linked chitosan having a partial structure as shown in Formula I: Wherein X is a substituted or unsubstituted C 1 -C 5 alkylene group. 如申請專利範圍第6項所述之經交聯之幾丁聚醣,其中X係為胺基所取代。 The cross-linked chitosan as described in claim 6 wherein X is substituted with an amine group. 一種製備經交聯之幾丁聚醣之方法,包括:利用二元酸或二元酸酐使幾丁聚醣藉由醯胺鍵之形成產生交聯結構。 A method for preparing a cross-linked chitosan, comprising: using a dibasic acid or a dibasic acid anhydride to form a crosslinked structure of chitosan by the formation of a guanamine bond. 如申請專利範圍第8項所述之方法,其中交聯結構之產生係於N,N-(3-二甲胺丙基)-N’-乙基-碳二亞胺以及N-羥基-琥珀醯亞胺之存在下進行。 The method of claim 8, wherein the crosslinked structure is produced by N,N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide and N-hydroxy-amber. It is carried out in the presence of quinone. 如申請專利範圍第9項所述之方法,其中N,N-(3-二甲胺丙基)-N’-乙基-碳二亞胺以及N-羥基-琥珀醯亞胺係溶於乙醇中。 The method of claim 9, wherein N,N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide and N-hydroxy-succinimide are dissolved in ethanol in. 如申請專利範圍第8項所述之方法,其中該二元酸或二元酸酐係選自丙二酸、丁二酸、丁二酸酐、戊二酸、戊二酸酐、天門冬酸、麩胺酸以及具有至少兩個羧基之聚乳酸所組成之群組。 The method of claim 8, wherein the dibasic acid or dibasic acid anhydride is selected from the group consisting of malonic acid, succinic acid, succinic anhydride, glutaric acid, glutaric anhydride, aspartic acid, glutamine. A group consisting of an acid and a polylactic acid having at least two carboxyl groups. 如申請專利範圍第8項所述之方法,其中二元酸或二元酸酐係加入幾丁聚醣溶液中以形成交聯結構。 The method of claim 8, wherein the dibasic acid or the dibasic acid anhydride is added to the chitosan solution to form a crosslinked structure. 一種根據申請專利範圍第8-12項中任一項所述之方法製得之經交聯之幾丁聚醣。A cross-linked chitosan prepared according to the method of any one of claims 8-12.
TW099124102A 2010-07-21 2010-07-21 Crosslinked chitosan and its preparation method TWI496791B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW099124102A TWI496791B (en) 2010-07-21 2010-07-21 Crosslinked chitosan and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW099124102A TWI496791B (en) 2010-07-21 2010-07-21 Crosslinked chitosan and its preparation method

Publications (2)

Publication Number Publication Date
TW201204745A TW201204745A (en) 2012-02-01
TWI496791B true TWI496791B (en) 2015-08-21

Family

ID=46761376

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099124102A TWI496791B (en) 2010-07-21 2010-07-21 Crosslinked chitosan and its preparation method

Country Status (1)

Country Link
TW (1) TWI496791B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775520B (en) * 2012-08-01 2014-06-18 浙江金壳生物化学有限公司 Chitosan aspartate freshener
CN102775519B (en) * 2012-08-01 2014-06-18 浙江金壳生物化学有限公司 Chitosan glutamate freshener
CN102775518B (en) * 2012-08-01 2014-06-18 浙江金壳生物化学有限公司 Chitosan succinate flavor enhancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070027068A1 (en) * 2001-10-10 2007-02-01 Defrees Shawn Erythropoietin: remodeling and glycoconjugation of erythropoietin
WO2009152691A1 (en) * 2008-06-17 2009-12-23 浙江大学 A polyglycol modified chitosan oligosaccharide fatty acid graft, preparation method thereof and use of the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070027068A1 (en) * 2001-10-10 2007-02-01 Defrees Shawn Erythropoietin: remodeling and glycoconjugation of erythropoietin
WO2009152691A1 (en) * 2008-06-17 2009-12-23 浙江大学 A polyglycol modified chitosan oligosaccharide fatty acid graft, preparation method thereof and use of the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Mariana Emilia Ghica, Rasa Pauliukaite, Orlando Fatibello-Filho, Christopher M.A. Brett, "Application of functionalized carbon nanotubess immobilized into chitosan films in amperometric enzyme biosensors",Sensors and Actua *

Also Published As

Publication number Publication date
TW201204745A (en) 2012-02-01

Similar Documents

Publication Publication Date Title
Fan et al. Preparation and characterization of chitosan/gelatin/PVA hydrogel for wound dressings
Bai et al. Tough and tissue-adhesive polyacrylamide/collagen hydrogel with dopamine-grafted oxidized sodium alginate as crosslinker for cutaneous wound healing
Pan et al. Non-stick hemostasis hydrogels as dressings with bacterial barrier activity for cutaneous wound healing
Liu et al. A highly-stretchable and adhesive hydrogel for noninvasive joint wound closure driven by hydrogen bonds
Konovalova et al. Preparation and biocompatibility evaluation of pectin and chitosan cryogels for biomedical application
Janarthanan et al. Self-crosslinking hyaluronic acid–carboxymethylcellulose hydrogel enhances multilayered 3D-printed construct shape integrity and mechanical stability for soft tissue engineering
Archana et al. Chitosan-pectin-alginate as a novel scaffold for tissue engineering applications
Wang et al. Interpenetrating network hydrogels with high strength and transparency for potential use as external dressings
Lu et al. Construction and function of robust and moist bilayer chitosan-based hydrogel wound dressing
Wang et al. Shape-recoverable hyaluronic acid–waterborne polyurethane hybrid cryogel accelerates hemostasis and wound healing
Tsao et al. Development of chitosan/dicarboxylic acid hydrogels as wound dressing materials
Iswariya et al. Design and development of a piscine collagen blended pullulan hydrogel for skin tissue engineering
Zhang et al. Detailed characterization of an injectable hyaluronic acid-polyaspartylhydrazide hydrogel for protein delivery
Sun et al. Mussel-inspired polysaccharide-based sponges for hemostasis and bacteria infected wound healing
Napavichayanun et al. Fibroin and polyvinyl alcohol hydrogel wound dressing containing silk sericin prepared using high-pressure carbon dioxide
Song et al. Kaolin-loaded carboxymethyl chitosan/sodium alginate composite sponges for rapid hemostasis
KR20160060519A (en) Alginate hydrogel for wound healing and manufacturing method of the same
Ross et al. Novel 3D porous semi-IPN hydrogel scaffolds of silk sericin and poly (N-hydroxyethyl acrylamide) for dermal reconstruction
Cao et al. Photo-crosslinked enhanced double-network hydrogels based on modified gelatin and oxidized sodium alginate for diabetic wound healing
TWI496791B (en) Crosslinked chitosan and its preparation method
Suneetha et al. Antibacterial, biocompatible, hemostatic, and tissue adhesive hydrogels based on fungal-derived carboxymethyl chitosan-reduced graphene oxide-polydopamine for wound healing applications
Zhang et al. Tunicate-mimetic antibacterial hydrogel based on metal ion crosslinking and chitosan functionalization for wound healing
Erden et al. Preparation and in vitro characterization of laminarin based hydrogels
Du et al. Heparin-based sericin hydrogel–encapsulated basic fibroblast growth factor for in vitro and in vivo skin repair
Qiu et al. Biocompatible and biodegradable Bletilla striata polysaccharides hydrogels crosslinked by BDDE for wound healing through the regulating of macrophage polarization

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees